Advanced Colorectal Cancer
Adenocarcinoma of the Caecum
Male, 46 years
Patient Internal ID: 1623344272
ICD-10 code
C18.0 Malignant Neoplasm of Caecum
Diagnosis (Incl. Metastases/Stage) and Year
February 2014
Adenocarcinoma of Caecum (G2), (KRAS mutated) with Omental Metastasis.
Disease progression in May 2020: Metastasis in Liver.
Previous Treatment
Chemotherapy (Avastin + FOLFOX), Surgery (Right Hemicolectomy, Omentectomy and Peritonectomy), HIPEC (Oxaliplatin), Chemotherapy (Avastin + FOLFOX), Chemotherapy (Avastin + FOLFIRI), Surgery (Hemi Hepatectomy), Chemotherapy (5-FU Grammont’s scheme), Percutaneous Transhepatic MW ablation of Liver.
Prognosis and Survival Expectation
The prognosis remains poor, with a median survival of Advanced Colorectal Cancer ~24 months from diagnosis.
5-year relative survival rates for Advanced Colon Cancer are 13%.
Treatment Provided
Allogeneic Umbilical Cord Blood Derived NK Cells (4 doses) and Curcumin Infusions over a period of 1 month. Autologous DCV (4 doses) and CIK (4 doses) over a period of 2 months.
Patient Survival/Condition and Year
Date of Review: 20/01/2024
The patient has survived for over 8 years since the diagnosis and 3 years after the recurrence and progression of the disease. It can be concluded that the addition of Immunotherapy, alongside Surgery and Chemotherapy, has extended patient survival by an estimate of 13 months.
